Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27699525

CC(C)(C)OC=O.CN(C1CCCCC1)S(=O)(=O)c1cccc(-c2c3c4ccccc4n2-3)c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ MCOLN3 Q8TDD5 2/20 0.44
▸ PTAFR P25105 1/20 0.39
▸ HTR2A P28223 7/20 0.38
▸ HTR2C P28335 5/20 0.38
▸ HTR1A P08908 2/20 0.38
▸ DRD2 P14416 2/20 0.38
▸ HTR7 P34969 2/20 0.38
▸ GAA P10253 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ CACNA1B Q00975 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ HPGD P15428 1/20 0.35
▸ RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27699524 0.76 ALDH1A1 (0.46) ALDH1A1KDM4EMEN1KMT2AMCOLN3
Tert-Butyl Formate SCHEMBL27720070 0.75 NR1H2 (0.38) ALDH1A1KDM4EKMT2AHTR1ADRD2
Tert-Butyl Formate SCHEMBL27699609 0.71 PARP1 (0.44) —
SCHEMBL5509270 0.70 NR1H2 (0.54) —
Tert-Butyl Formate SCHEMBL27699544 0.70 PTGS2 (0.34) —
Tert-Butyl Formate SCHEMBL27699608 0.70 PTGES2 (0.35) —
Tert-Butyl Formate SCHEMBL27720083 0.68 HTR6 (0.32) —
Tert-Butyl Formate SCHEMBL27699536 0.67 — —
SCHEMBL4159760 0.66 ALDH1A1 (1.00) ALDH1A1KDM4EMEN1KMT2AMCOLN3
Tert-Butyl Formate SCHEMBL28781898 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101146770-A 2-phenyl indoles as prostaglandin D2 receptor antagonists AVENTIS PHARMA INC (US) 2008-03-19 — — CN disclosed
Send feedback